Adagene (ADAG) Invested Capital (2019 - 2025)
Adagene's (ADAG) quarterly Invested Capital came in at $711.4 billion in Q4 2025, down 94.5% year-on-year from $12923.6 billion in Q4 2024, and up 15668621.15% on a QoQ basis from $4.5 million in Q2 2025.
Adagene (ADAG) Invested Capital (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Invested Capital data on file, last reported at $711.4 billion in Q4 2025.
- On a quarterly basis, Invested Capital fell 94.5% year-over-year to $711.4 billion in Q4 2025; TTM through Dec 2025 was $13635.0 billion, a 30.72% decrease from a year earlier, with the FY2025 full-year figure at $711.4 billion, down 94.5% from the prior year.
- Invested Capital for Q4 2025 stood at $711.4 billion, up from $4.5 million in the prior quarter.
- Over the last five years, Invested Capital for ADAG reached as high as $12923.6 billion in Q4 2024 and fell as low as $358958.0 in Q4 2021.
- Historically, Invested Capital has averaged $2459.4 billion across 5 years, with a median of $1031.8 billion in 2022.
- Across the five-year window, Invested Capital jumped 794000312.3% in 2022 and slumped 100.0% in 2024, its largest moves.
- Year by year, Invested Capital stood at $358958.0 in 2021, then soared by 794000312.3% to $2850.1 billion in 2022, then surged by 46.01% to $4161.5 billion in 2023, then surged by 210.55% to $12923.6 billion in 2024, then sank by 94.5% to $711.4 billion in 2025.
- Per Business Quant data, the three most recent Invested Capital figures were $711.4 billion in Q4 2025, $4.5 million in Q2 2025, and $12923.6 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - | 711.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 711.36 Bn |
| Jun 30, 2025 | 4.54 Mn |
| Dec 31, 2024 | 12,923.60 Bn |
| Jun 30, 2024 | 11.77 Mn |
| Dec 31, 2023 | 4,161.55 Bn |
| Jun 30, 2023 | 2,594.87 Bn |
| Dec 31, 2022 | 2,850.13 Bn |
| Jun 30, 2022 | 1,352.18 Bn |
| Dec 31, 2021 | 358,958.00 |
| Jun 30, 2021 | 1.82 Mn |
| Dec 31, 2020 | 2.54 Mn |
| Dec 31, 2019 | 322,525.00 |